In this study, we show that LOX is downregulated in the CRPC due to its promoter hypermethylation and characterize the role of LOX in PCa cells, and that LOX downregulation contributes to progression via IGFBP3, and that the restoration of LOX may be a promising therapeutic strategy for PCa. The gene discussed is IGFBP3; the disease is posterior cortical atrophy.